Sanofi India Limited (SANOFI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sanofi India Limited (SANOFI) has a cash flow conversion efficiency ratio of 0.585x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs4.38 Billion ≈ $47.40 Million USD) by net assets (Rs7.49 Billion ≈ $81.02 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see SANOFI stock market capitalisation for the company's overall valuation and market capitalisation.
Sanofi India Limited - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Sanofi India Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Sanofi India Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sanofi India Limited ranked by their cash flow conversion efficiency. Explore earnings quality score of Sanofi India Limited to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Fujian Foxit Software Development Joint Stock Co Ltd
SHG:688095
|
0.024x |
|
Jilin Expressway Co Ltd
SHG:601518
|
0.038x |
|
L&C Bio Co. Ltd
KQ:290650
|
0.014x |
|
Vishay Precision Group Inc
NYSE:VPG
|
0.001x |
|
CSBC Corp Taiwan
TW:2208
|
-0.623x |
|
HomeTrust Bancshares, Inc.
NYSE:HTB
|
0.187x |
|
Vina Concha To
SN:CONCHATORO
|
-0.032x |
|
Chief Telecom Inc
TWO:6561
|
0.122x |
Annual Cash Flow Conversion Efficiency for Sanofi India Limited (2004–2025)
The table below shows the annual cash flow conversion efficiency of Sanofi India Limited from 2004 to 2025. View latest Sanofi India Limited stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Rs7.49 Billion ≈ $81.02 Million |
Rs4.51 Billion ≈ $48.76 Million |
0.602x | +12.23% |
| 2024-12-31 | Rs8.61 Billion ≈ $93.07 Million |
Rs4.62 Billion ≈ $49.91 Million |
0.536x | +136.29% |
| 2023-12-31 | Rs10.15 Billion ≈ $109.79 Million |
Rs2.30 Billion ≈ $24.92 Million |
0.227x | -27.38% |
| 2022-12-31 | Rs12.76 Billion ≈ $137.97 Million |
Rs3.99 Billion ≈ $43.12 Million |
0.313x | +24.47% |
| 2021-12-31 | Rs22.26 Billion ≈ $240.69 Million |
Rs5.59 Billion ≈ $60.43 Million |
0.251x | -12.94% |
| 2020-12-31 | Rs21.19 Billion ≈ $229.16 Million |
Rs6.11 Billion ≈ $66.09 Million |
0.288x | +70.83% |
| 2019-12-31 | Rs24.42 Billion ≈ $264.13 Million |
Rs4.12 Billion ≈ $44.59 Million |
0.169x | +0.20% |
| 2018-12-31 | Rs22.19 Billion ≈ $240.00 Million |
Rs3.74 Billion ≈ $40.44 Million |
0.168x | -21.53% |
| 2017-12-31 | Rs20.26 Billion ≈ $219.15 Million |
Rs4.35 Billion ≈ $47.05 Million |
0.215x | +15.52% |
| 2016-12-31 | Rs17.36 Billion ≈ $187.70 Million |
Rs3.23 Billion ≈ $34.89 Million |
0.186x | +41.87% |
| 2015-12-31 | Rs16.27 Billion ≈ $175.97 Million |
Rs2.13 Billion ≈ $23.05 Million |
0.131x | -26.53% |
| 2014-12-31 | Rs14.86 Billion ≈ $160.69 Million |
Rs2.65 Billion ≈ $28.65 Million |
0.178x | -11.89% |
| 2013-12-31 | Rs13.47 Billion ≈ $145.64 Million |
Rs2.73 Billion ≈ $29.48 Million |
0.202x | -14.90% |
| 2012-12-31 | Rs12.04 Billion ≈ $130.22 Million |
Rs2.86 Billion ≈ $30.97 Million |
0.238x | +29.53% |
| 2011-12-31 | Rs11.17 Billion ≈ $120.76 Million |
Rs2.05 Billion ≈ $22.17 Million |
0.184x | +42.45% |
| 2010-12-31 | Rs10.14 Billion ≈ $109.68 Million |
Rs1.31 Billion ≈ $14.14 Million |
0.129x | -12.71% |
| 2009-12-31 | Rs9.32 Billion ≈ $100.77 Million |
Rs1.38 Billion ≈ $14.88 Million |
0.148x | +2.28% |
| 2008-12-31 | Rs8.29 Billion ≈ $89.66 Million |
Rs1.20 Billion ≈ $12.95 Million |
0.144x | -1.97% |
| 2007-12-31 | Rs7.07 Billion ≈ $76.44 Million |
Rs1.04 Billion ≈ $11.26 Million |
0.147x | -27.73% |
| 2006-12-31 | Rs6.08 Billion ≈ $65.78 Million |
Rs1.24 Billion ≈ $13.40 Million |
0.204x | -32.31% |
| 2005-12-31 | Rs5.24 Billion ≈ $56.65 Million |
Rs1.58 Billion ≈ $17.05 Million |
0.301x | +77.53% |
| 2004-12-31 | Rs4.22 Billion ≈ $45.62 Million |
Rs715.33 Million ≈ $7.74 Million |
0.170x | -- |
About Sanofi India Limited
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company offers pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, anti-infectives, and central nervous system under the Lantus, Toujeo, Soliqua, Clexane, Amaryl, Cardace, Lasix, Lasilactone, Glimepiride, Cetapin, Targocid, Frisium, Targoci… Read more